The expression of Smad interacting protein-1 (SIP1; ZEB2) and the de novo expression of vimentin are frequently involved in epithelial-to-mesenchymal transitions (EMTs) under both normal and pathological conditions. In the present study, we investigated the potential role of SIP1 in the regulation of vimentin during the EMT associated with breast tumor cell migration and invasion. Examining several breast tumor cell lines displaying various degrees of invasiveness, we found SIP1 and vimentin expression only in invasive cell lines. Also, using a model of cell migration with human mammary MCF10A cells, we showed that SIP1 is induced specifically in vimentin-positive migratory cells. Furthermore, transfection of SIP1 cDNA in MCF10A cells increased their vimentin expression both at the mRNA and protein levels and enhanced their migratory abilities in Boyden Chamber assays. Inversely, inhibition of SIP1 expression by RNAi strategies in BT-549 cells and MCF10A cells decreased vimentin expression. We also showed that SIP1 transfection did not activate the TOP-FLASH reporter system, suggesting that the b-catenin/ TCF pathway is not implicated in the regulation of vimentin by SIP1. Our results therefore implicate SIP1 in the regulation of vimentin observed in the EMT associated with breast tumor cell migration, a pathway that may contribute to the metastatic progression of breast cancer.
Introduction
During their metastatic conversion, epithelial cells acquire the ability to invade the surrounding tissue and disseminate into secondary organs. There is mounting evidence that the acquisition of migratory and invasive properties by epithelial cells is associated with the gain of mesenchymal characteristics and the loss of epithelial features, a phenomenon referred to as epithelial-to-mesenchymal transition (EMT) (Savagner, 2001; Thiery, 2002; Gotzmann et al., 2004; Gilles et al., 2004) .
A growing number of zinc-finger transcription factors has now been implicated in the regulation of EMT phenomena. Among them is SIP1 (Smad Interacting Protein-1) or ZEB2, a large zinc-finger protein that, together with dEF1, belongs to a small family of transcriptional repressors. It has originally been identified as a factor binding the Smad proteins, implicated in the signaling by TGF-b . The dEF1/ZEB family comprises two vertebrate prototypes (dEF1/ZEB1 and SIP1/ZEB2) characterized by two zinc-finger clusters separated by a homeodomain. The N-terminal and C-terminal zinc-finger clusters are made of four and three zinc fingers, respectively. Each zincfinger cluster recognizes a CACCT motif on the DNA but the full-length SIP1 molecule has been shown to bind a bipartite element composed of one 5 0 -CACCT and one 5 0 -CACCTG sequence Verschueren et al., 1999) . A mechanism by which SIP1 might contribute to EMT processes is through its ability to downregulate E-cadherin. Indeed, SIP1 has been shown to bind the E-cadherin promoter and to downregulate the expression of this cell adhesion protein (Comijn et al., 2001; van Grunsven et al., 2003) . E-cadherin is a transmembrane glycoprotein that mediates homotypic cell-cell contacts between epithelial cells and, thereby, largely contributes to the cohesive architecture of normal epithelia. The cytoplasmic part of E-cadherin is associated with the actin cytoskeleton via its cytoplasmic binding partners, the catenins (a-, b-and g-catenin). Under particular conditions, when b-catenin is not sequestered in the junctional E-cadherin complexes, it can translocate in the nucleus where it acts as a transcriptional coactivator through its binding with the members of the TCF/LEF-1 (T-cell factor/lymphoid enhancer factor) transcription factor family (Bienz, 2005) . Downregulation of E-cadherin expression and reorganization of E-cadherin-based adhesion junctions are considered hallmarks of EMT processes and have largely been implicated in EMT associated with the acquisition of a migratory/invasive phenotype by epithelial tumor cells (Comijn et al., 2001; Van Aken et al., 2001; Peinado et al., 2004) .
Besides the disorganization of E-cadherin-based junctional complexes, the de novo expression of vimentin is also frequently associated with EMT processes and with the metastatic conversion of epithelial cells. Vimentin is a type-III intermediate filament normally expressed in cells of mesenchymal origin (Steinert and Roop, 1988) . However, numerous data have now demonstrated that vimentin can also be expressed in epithelial cells when they become involved in physiological or pathological processes requiring epithelial cell migration. Vimentin has indeed been described in migratory epithelial cells involved in embryonic and organogenesis processes, in placentation, wound healing and tumor invasion (Ramaekers et al., 1983; Guarino, 1995; Gilles and Thompson, 1996; Gilles et al., 1999 Gilles et al., , 2003 . Also, vimentin-specific antisense cDNA or oligonucleotide transfection in vimentin-expressing cell lines was shown to reduce their in vitro invasiveness or migration, strongly emphasizing a functional contribution of vimentin to epithelial cell invasion/migration (Hendrix et al., 1997; Gilles et al., 1999; Singh et al., 2003) . Accordingly, impaired wound healing has been observed in vimentin knockout mice (Eckes et al., 1998 (Eckes et al., , 2000 . Furthermore, a direct or indirect interaction of vimentin with microfilaments and microtubules and more particularly with molecules such as plectin or integrins has been described (Svitkina et al., 1996; Maniotis et al., 1997; Homan et al., 1998; Goldman et al., 1999; Wu et al., 1999; Gonzales et al., 2001; Tsuruta and Jones, 2003; Helfand et al., 2004; Kreis et al., 2005) . A role of vimentin in the mechanical transduction of signals from the cell surface to the nucleus and in the overall reorganization of the cytoskeleton associated with cell motility and migration has therefore been suggested (Hendrix et al., 1996; Gilles et al., 1999; Eckes et al., 2000; Helfand et al., 2004) .
Because both SIP1 and vimentin expression are clearly associated with EMT events, we thus examined in the present study the implication of SIP1 in the induction of vimentin expression associated with epithelial cell migration and invasion. We also explored the potential role of the b-catenin/TCF pathway in this regulation.
Results
Vimentin expression correlates with SIP1 expression in migratory/invasive breast cell lines In order to examine the relationship between SIP1 and vimentin, we first analysed their expression in two noninvasive (MCF-7, T47D) and three invasive (MDA-231, BT549, Hs578T) epithelial breast cancer cell lines. The invasive phenotype of these breast cancer cells, as assessed by modified Boyden chamber assays, as well as their vimentin and E-cadherin expression status have been characterized in previous studies which established a clear association between high invasive properties and EMT traits such as vimentin expression and lack of E-cadherin expression (Thompson et al., 1992; Sommers et al., 1994; Nawrocki et al., 2001) . Examining SIP1 in this set of breast cell lines, we observed that invasive breast cancer cell lines showed both SIP1 and vimentin mRNA expression in contrast to non-invasive cells (Figure 1 ). SIP1 and vimentin mRNA expression was also analysed in primary airway human fibroblasts versus primary human differentiated epithelial cells. Cells isolated from airway tissues were used because of the possibility to obtain a clear epithelial differentiation, characterized by the presence of ciliated cells, when cultivated in appropriate culture conditions. In support of the results obtained with the tumor cell lines suggesting that the invasive cell lines have gained mesenchymal characteristics, a weak expression of vimentin and no detectable expression of SIP-1 was found in differentiated lung epithelial cells whereas both mRNA were strongly co-expressed in fibroblasts ( Figure 1) .
Next, we studied SIP1 expression in relation to vimentin expression in a migration assay that we had previously used to demonstrate the transient expression of vimentin during epithelial cell migration (Gilles et al., 1999 (Gilles et al., , 2003 . Briefly, in this migration assay, MCF10A human breast cells are plated at high density in a glass ring and migrate as an outgrowth after the removal of the ring. In this assay, vimentin expression has been shown to vary in relationship with the migratory status of the cells. Using video microscopy, we indeed previously demonstrated that the subpopulation of cells at the periphery of the outgrowth is involved in an orientated migration and undergoes an EMT process characterized by the de novo expression of vimentin and a relocalization of E-cadherin and b-catenin (Gilles et al., 1999 (Gilles et al., , 2003 . In contrast, the stationary cells in the Gilles et al., 1999) . The VP-EGFP MCF10A cells were plated in the migration assays and sorted by FACS to physically separate the GFP-positive and the GFPnegative populations (Figure 2a ). RT-PCR performed on these two separated cell populations clearly showed co-expression of SIP1 and vimentin mRNA in the migratory subpopulation (Figure 2b ). The effect of EGF on vimentin and SIP1 coexpression was also investigated in this assay. We indeed previously showed that EGF, which is present in the Vimentin regulation by SIP1 S Bindels et al growth medium of the MCF10A cells, induces vimentin expression in migratory MCF10A cells even in the absence of serum. Similar to our observations in the presence of complete growth medium (containing FCS and EGF) (Figure 2b ), a strong co-expression of vimentin and SIP1 mRNA was also found in the migratory subpopulation of the two clones of VP-EGFP MCF10A plated in EGF-containing, serum-free medium (Figure 2c ).
Smad interacting protein-1 regulates vimentin expression
Because of the correlation between vimentin and SIP1 expression in both the breast cancer cell line panel and the MCF10A migration assay, we examined whether SIP1 could regulate vimentin expression. We first observed that transient transfection of SIP1 cDNA for 24, 48 or 72 h clearly induced vimentin expression both at the mRNA ( Figure 3a ) and at the protein (Figure 3b ) levels. This correlated with increased migratory properties in the Boyden chamber assay ( Figure 3c ).
Inversely, we investigated the effect of an inhibition of SIP1 on vimentin expression using RNAi strategies both on MCF10A cells and on vimentin-positive BT549 cells. Because an efficient diminution of SIP1 could not be achieved in MCF10A cells by transient transfection of SIP1 siRNA, these cells were transduced with two lentiviral constructs expressing two different SIP1 short hairpin RNA (shRNA) sequences which efficiently diminished SIP1 mRNA levels ( Figure 4a ). The SIP1 shRNA construct transduction also diminished vimentin expression both at the mRNA (60% decrease compared to control transduced cells) and at the protein level (Figure 4a and b). This was associated with a diminution of migratory properties in the Boyden chamber assay (Figure 4c ). Strengthening these data obtained with MCF10A cells, we also showed that transient transfections of two species of SIP1 siRNA in vimentin-positive BT549 cells significantly decreased vimentin mRNA levels (34 and 28% decrease for siRNA 1 and 2, respectively) ( Figure 5a ). A decrease of vimentin protein expression was also observed (Figure 5b ).
Because vimentin has been shown to be a target of the b-catenin/TCF pathway (Gilles et al., 2003) and because SIP1 has been described as a potent transcriptional repressor of E-cadherin (Comijn et al., 2001; van Grunsven et al., 2003) , we examined whether the regulation of vimentin by SIP1 involved the b-catenin/ TCF pathway. A downregulation of E-cadherin may indeed result in increased availability of b-catenin in the nucleus. We thus first confirmed that SIP1 and E-cadherin expression were inversely correlated in the breast tumor cell lines (Figure 6a ). This was also seen in the MCF10A migration assay (Figure 6b ). Furthermore, transfection of SIP1 cDNA in MCF10A cells decreased the level of E-cadherin mRNA in these cells (Figure 6c ). In order to analyse the implication of the b-catenin/TCF pathway in SIP1-induced vimentin expression, we next examined the ability of SIP1 to transactivate a luciferase reporter plasmid containing wild-type (TOP-FLASH) or mutated (FOP-FLASH) b-catenin/TCF-binding sites as regulatory elements. Although SIP1 cDNA transfection clearly activated the vimentin promoter reporter 
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S Bindels et al construct (Figure 7a ), it failed to activate the TOP-FLASH reporter system ( Figure 7b ). This suggests that SIP1 does not activate the b-catenin/TCF pathway. Accordingly, we did not observe any increase of b-catenin in the nuclear fraction (nor in the membranous or cytosolic fractions) of cells transfected with SIP1 cDNA though the presence of the myc-tagged SIP1 was detected (Figure 7c ). Since it has been suggested that the NH 2 -unphosphorylated form of bcatenin is mainly implicated in the transcriptional activity of b-catenin (Staal et al., 2002) , we also examined this particular form of b-catenin. Using a specific antibody against the unphosphorylated bcatenin, we still did not observe any increase of this particular form in the nuclei of SIP1-transfected cells (data not shown).
Discussion
In the present study, we demonstrate that SIP1 regulates vimentin expression in epithelial cells and emphasize the implication of this regulation in epithelial breast cancer cell migration/invasion. We indeed show that (1) SIP1 expression coincided with vimentin expression in invasive breast tumor cell lines, (2) SIP1 and vimentin expression were specifically induced in migratory epithelial MCF10A cells, (3) SIP1 cDNA transfection increased vimentin expression and migratory abilities of MCF10A cells, (4) SIP1-specific siRNA or shRNA diminished vimentin expression in invasive breast tumor cell lines and (5) the activation of the vimentin promoter by SIP1 was not associated with the activation of the b-catenin/TCF/LEF signaling pathway. Upon examination of several human breast cancer cell lines, we found a clear correlation between vimentin and SIP1 expression in invasive cell lines. A correlation between vimentin and SIP1 expression was also obvious in the assay of MCF10A cell migration. Previously, this Vimentin regulation by SIP1 S Bindels et al dynamic model allowed to clearly show the induction of vimentin during cell migration, discriminating a subpopulation of migratory, vimentin-positive cells from a vimentin-negative, stationary subpopulation within the same cell line (Gilles et al., 1999) . Here, we were able to demonstrate increased SIP1 expression specifically in the vimentin-positive migratory subpopulation. In agreement with previous studies (Sommers et al., 1994; Comijn et al., 2001; Gilles et al., 2003) , a lower level of E-cadherin was observed both in the invasive cell lines, as well as in the migratory subpopulation of MCF10A, also attesting the EMT-derived phenotype of these invasive and migratory cells expressing SIP1. In line with our observations, SIP1 expression has been associated with migratory and invasive mechanisms occurring during embryonic development. Indeed, a high level of SIP1 has been detected during the formation of the neural tube and this has been shown to play a key role in the migration of neural crest cells (Eisaki et al., 2000; van Grunsven et al., 2000; , a system largely described as a physiological archetypal model of EMT (Duband et al., 1995; Tucker, 2004) . Also, an increased expression of SIP1 has been described in NMuMG cells which have undergone a TGFb1-induced EMT characterized by decreased E-cadherin expression and increased N-cadherin expression (Maeda et al., 2005) . Our results thus demonstrate a relationship between SIP1 and an EMT-derived phenotype characterized by vimentin expression, and further emphasize the implication of this relationship in dynamic cell migration.
We further observed that transfection of SIP1 cDNA in MCF10A cells increased vimentin expression both at the mRNA and protein level, which was associated with increased migratory ability. Inversely, the expression of 
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S Bindels et al SIP1-specific shRNAs in MCF10A cells clearly diminished vimentin expression as well as their migratory properties. Strengthening these data, a diminution of vimentin expression following SIP1 siRNA transfection was also shown in BT549 breast tumor cells. Up to now, the implication of SIP1 in EMT phenomena associated with tumor cell invasion has been more particularly linked to its ability to repress E-cadherin, as shown in MDCK cells and in hepatocellular and colon epidermoid carcinoma cells transfected with SIP1 (Comijn et al., 2001; Miyoshi et al., 2004; Vandewalle et al., 2005) . A repression of E-cadherin by SIP1 was accordingly observed in our cell systems. Overall, an increasing number of zinc-finger transcription factors, including Snail and Slug, both belonging to the Snail family, have been described as E-cadherin repressors and have been implicated in the regulation of EMT phenomena (Nieto, 2002; Come et al., 2004) . Forcing the expression of these factors in a variety of epithelial cell systems was found to induce EMT processes characterized by decreased E-cadherin levels and by increased migratory/invasive properties (Cano et (Miyoshi et al., 2004) . Thus, together with our observations that expression of endogenous vimentin and SIP1 associates with migratory/invasive abilities, these results suggest that SIP1 can contribute to the upregulation of vimentin transcription such as that occurs during epithelial cell migration/invasion. The mechanism by which SIP1 regulates vimentin remains unclear. SIP1 has been described as a transcriptional repressor downregulating target genes through direct binding of bipartite elements made of one 5 0 -CACCT-3 0 and one 5 0 -CACCTG-3 0 sequence (Remacle et al., 1999). The fact that vimentin is upregulated by SIP1 and that no such bipartite element could be found in the vimentin promoter sequence suggested that vimentin regulation by SIP1 is most likely indirect. Considering the repressive effect of SIP1 effect on E-cadherin (Comijn et al., 2001; van Grunsven et al., 2003) , it was tempting to speculate that SIP1 induction of vimentin could depend on the activation of the b-catenin/TCF pathway. Although it is not always observed (Comijn et al., 2001) , diminished E-cadherin expression could indeed favor translocation of b-catenin in the nucleus where it can trigger the transcription of several target genes through binding with members of the TCF/LEF transcription factor family (Hecht and Kemler, 2000; Giles et al., 2003) . Furthermore, vimentin has been shown to be a target of the b-catenin/TCF pathway (Gilles et al., 2003) . However, our present results rather suggest that the b-catenin/TCF pathway is not activated following SIP1 transfection, as also observed by Comijn et al. (2001) in MDCK cells. Indeed, transfection of SIP1 cDNA into MCF10A cells did not lead to an increase in the TOP-FLASH reporter system though it activated the vimentin promoter. Also, in agreement with our TOP-FLASH results, we did not observe any accumulation of nuclear b-catenin in SIP1-transfected MCF10A cells. It has also to be noticed that SIP1 downregulation by siRNA in invasive BT549 cells, which do not express E-cadherin, can also modulate vimentin expression. Taken together, these data therefore suggest that regulation of vimentin by SIP1 can be independent of E-cadherin expression and does not necessarily rely in modulations of the b-catenin/TCF pathway. Nevertheless, many other indirect mechanisms could be involved. Additionally, the possibility that SIP1 could directly bind to and activate the vimentin promoter (through the binding of a single CACCT motif or another motif similar in sequence) cannot be excluded and is currently under investigation.
In conclusion, our results clearly demonstrate that SIP1 and vimentin expression correlate with a migratory/invasive phenotype and that SIP1 can regulate vimentin expression in epithelial breast tumor cells. Because of the established functional role of vimentin in cell migration, the upregulation of vimentin by SIP1 has implications for all processes requiring epithelial cell migration including tumor cell invasion.
Materials and methods

Cell culture
All human mammary epithelial cells used were obtained from the American Type Culture Collection (Rockville, MD, USA). MCF10A-VP-EGFP cells were generated previously by stable transfection of MCF10A cells with the VP-EGFP plasmid in which the human vimentin promoter controls the expression of EGFP (Gilles et al., 1999) . MCF-7, T47D, MDA-MB-231, BT549 and Hs578T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% FCS. MCF10A cells were grown in a 1:3 (v/v) mixture of HAM F12 and DMEM, supplemented with 20 mg/ml of adenine, 5 mg/ml of insulin, 0.5 mg/ml of hydrocortisone, 2 ng/ml of EGF, 5 mg/ml of transferrin, 1.5 ng/ml of triiodothyronin and 10% FCS.
Primary epithelial cells and primary fibroblasts were isolated from human polyps as previously described (Million et al., 2001) . Primary epithelial cells were allowed to differentiate, as attested by the presence of ciliated cells, in a transwell chamber coated with collagen type I for 12 days (Million et al., 2001) .
In vitro migration assay In order to sort by FACS the vimentin-expressing migratory cells from the stationary, vimentin-negative cells, we used two clones of MCF10A-VP-EGFP expressing the EGFP reporter Vimentin regulation by SIP1 S Bindels et al gene driven by the vimentin promoter (MCF10A-VP-EGFP #11 and #12 as also described in Gilles et al., 1999) . These cells were analysed in a migration assay as described previously (Gilles et al., 1999) . Briefly, 5 Â 10 4 cells were seeded in growth medium inside a 6-mm glass ring. At 24 h after plating, the glass ring was removed and the cells were covered either with complete growth medium (containing FCS and EGF) or with FCS-free growth medium in order to examine the implication of EGF. In this model, the cells migrate as an outgrowth from the confluent area initially delimited by the ring. We have previously shown that cells at the periphery of the outgrowth are implicated in an oriented migration and express vimentin and GFP. In contrast, the cells in the area initially delimited by the ring are rather stationary and do not express vimentin nor GFP (Gilles et al., 1999) . At 48 h after the removal of the ring, the cells were collected by trypsinization of 24 migration assays and were sorted by FACS (FACSVantage-SE, Becton Dickinson, Erembodegem, Belgium) into EGFP-positive and EGFP-negative populations, which were then used for RNA extraction and RT-PCR analysis.
Immunofluorescence Cells cultured in the migration assay on glass coverslips were fixed in paraformaldehyde (4% in PBS) for 10 min and then permeabilized with 0.1% Triton X-100 for 1 min at room temperature. The coverslips were then blocked for 30 min with 3% BSA in PBS. After several washes with PBS, fixed monolayers were incubated for 1 h with a monoclonal antibody to vimentin (clone V9, Dako, Glostrup, Denmark) and then exposed to a TRITC-conjugated rabbit anti-mouse antibody (Dako). Finally, nuclei were labeled with 4 0 ,6-diamidino-2-phenylindole (DAPI; 1 mg/ml) for 20 min. The coverslips were then mounted with Aquapolymount antifading solution (Agar, UK) onto glass slides and observed under a fluorescence microscope (Olympus, Tokyo, Japan).
Plasmids
The vimentin promoter luciferase reporter vector (VimPro) used in this study has been characterized previously (Gilles et al., 2003) . This plasmid consists of the human vimentin promoter cloned into the firefly luciferase reporter plasmid pGL-3 (Promega, Madison, WI, USA).
The expression vector for the SIP1 cDNA encoding a myctagged protein has been described previously Comijn et al., 2001 ).
An expression vector encoding a mutated form of b-catenin which is less susceptible to degradation was kindly provided by Dr K Orford and Dr S Byers (Lombardi Cancer Center, Georgetown University, Washington, DC, USA) (Orford et al., 1997) . Dr HC Clevers (University Hospital, Utrecht, The Netherlands) donated the expression vector encoding human TCF-4 (pCDNA-hTCF4) and the TOP-FLASH and FOP-FLASH plasmids containing, respectively, three wildtype (5 0 -CCTTTGATC-3 0 : TOP-FLASH) or mutated (5 0 -CCTTTGGCC-3 0 : FOP-FLASH) copies of the b-catenin/ TCF-binding sites upstream of a minimal c-fos promoter driving the expression of firefly luciferase (Korinek et al., 1997; van de Wetering et al., 1997) .
Luciferase reporter assay
Transient transfections were performed with Fugene transfection reagent (Roche, Branchburg, NJ, USA) on 50 000 cells plated in a 24-well plate half an hour before the addition of the DNA/Fugene mixture.
For the determination of the vimentin promoter induction by SIP1, each well was supplemented with a mixture containing 20 ml of serum-free DMEM, 0.6 ml of Fugene and 0.2 mg of the promoter reporter construct (either VimPro, TOP-FLASH or FOP-FLASH reporter construct), 0.2 mg of the SIP1 expression vector (or the backbone vector control) and 1.6 ng of the Renilla luciferase reporter phRG-TK (Promega) used as an internal control. For b-catenin/TCF-4 induction, each well was incubated with a mixture containing 20 ml of serum-free DMEM, 0.6 ml of Fugene, 0.15 mg of the firefly luciferase reporter plasmid (either VimPro, TOP-FLASH or FOP-FLASH reporter construct), 0.15 mg of the b-catenin expression vector (or the corresponding backbone vector), 0.15 mg of the TCF-4 expression vector (or the corresponding backbone vector) and 1.6 ng of the Renilla luciferase vector phRG-TK.
At 24 h after transfection, the cells were lysed in 100 ml of lysis buffer followed by determination of luciferase activity in 20 ml of lysate with a luminometer using the Dual Luciferase Assay System (Promega). The firefly luciferase activity was normalized to the activity of the Renilla luciferase used as internal control. Results were expressed as fold induction, calculated by dividing the normalized values obtained following cDNA transfection by the normalized values obtained following transfection of the corresponding backbone expression vector. To assess the b-catenin/TCF/LEF activities using the TOP/FOP-FLASH reporter system, the normalized values obtained with the FOP-FLASH reporter plasmid were subtracted from the normalized values obtained with the TOP-FLASH reporter plasmid. Results were then expressed as fold induction relative to the value obtained in the cells transfected with the control vector. Each experiment was performed at least three times in triplicate. Data are expressed as means7s.e. A one-sample t-test was performed and a P-value o0.05 was considered significant.
Transient transfections of Smad interacting protein-1 cDNA
To study the regulation of the endogenous vimentin gene by SIP1, 150 000 MCF10A cells plated in six-well plates were transiently transfected with the SIP1 expression vector using Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA, USA). At 24 h after plating, transfection was carried out as recommended by the manufacturer by adding, in each well, a mixture containing 500 ml of serum-free medium, 3 ml of Lipofectamine 2000 and 2 mg of the SIP1 expression vector. As control, cells were transfected with the corresponding backbone vector. At 24, 48 and 72 h after transfection, cells were collected for RT-PCR or Western blotting analyses. A control transfection condition using a plasmid encoding GFP (pEGFP-IRESpuro, Clontech, CA, USA) was always performed in parallel to determine the transfection efficiency. All experiments were set up to obtain at least 70% of transfected cells.
Transfection of small interfering RNA Two 19-nt-specific sequences were selected in the coding sequence of SIP1 to generate 21-nt sense and 21-nt antisense strands of the type (19N) TT (N, any nucleotide). The sense and antisense strands were then annealed to obtain duplexes with identical 3 0 overhangs. The sequences were submitted to a BLAST search against the human genome to ensure the specificity of the small interfering RNA (siRNA) to the targeted sequence. Two duplexes, which do not recognize any sequence in the human genome, were used as controls. The 19-nt-specific sequences for the two SIP1 siRNAs are as follows: SIP1 Si1, 5 0 -GGUAAUCGCAAGUUCAAAU-3 0 ; SIP1 Si2, 5 0 -GAACAGACAGGCUUACUUA-3 0 . For transfection of the siRNA duplexes, 75 000 cells were plated in six-well plates in 2 ml/well of culture medium. At 24 h after plating, the cells were transfected by phosphate calcium precipitation by adding in each well 200 ml of a mixture containing the siRNA duplexes (20 nM), 140 mM NaCl, 0.75 mM Na 2 H-PO 4 , 6 mM glucose, 5 mM KCl, 25 mM HEPES and 125 mM CaCl 2 . At 24 h after transfection, the cells were extensively washed with PBS and incubated for 48 h in culture medium before they were harvested for RT-PCR analyses or Western blotting analyses. The transfection of an FITC-labelled control siRNA (Eurogentec, Belgium) was also performed in parallel and revealed an uptake of the siRNA in 100% of the cells.
Transduction of the lentiviral vector for SIP1 short hairpin RNA A SIP1-specific siRNA sequence was designed using selection criteria as described (Brummelkamp et al., 2002; Ui-Tei et al., 2004) . A double PCR approach was used to create shRNA expression cassettes containing the H1 promoter and both the sense and antisense shRNA sequences with a loop sequence in between. In a first step, PCR was performed using pSuper plasmid (Brummelkamp et al., 2002) as a template, the H1 promoter primer 5 0 -CTGCAGGAATTCGAACGCTGACGT CATCAA-3 0 and the sense shRNA oligonucleotide 5-AAATC TCTTGAATTTAACAATACCCAGCTCCGGGGATCTGT GGTCTCATACAGAACTTATAA-3
. This PCR product was a template for a second PCR reaction with the same H1 promoter primer and the antisense shRNA oligonucleotide 5
The shRNA expression cassette was cloned in the lentiviral pLV-TH vector (Wiznerowicz and Trono, 2003) using EcoRI and ClaI restriction sites.
For lentivirus production, 1.2 million cells of the packaging cell line HEK293T were seeded in a 25-cm 2 flask. After 24 h, 3 mg of the pLV-THshRNA construct or empty vector, 3 mg of the packaging plasmid pCMVdR8.91 and 1.5 mg of the envelope plasmid pMD2G-VSVG were first precipitated together and then transfected into the HEK293T cells using the calcium phosphate precipitation method. The DNA was premixed with 50 ml of 2 M CaCl 2 and 190 ml TE buffer and then slowly added to 250 ml 2 Â HBS. The mixture was put on a shaker for 15 min before it was added to the cells. After 8 h, the cells were washed and incubated for 48 h in 4 ml fresh culture medium. The virus-containing medium was then harvested and filtered through a 0.45 mm low protein binding filter unit (Millipore, Billerica, MA, USA). Aliquots were stored at À701C.
Transduction of the MCF10A cells was performed by mixing 50 000 cells with 200 ml viral supernatant in a 96-well plate and three replicates of each transduction were made. These mixtures were centrifuged for 1.5 h at 321C and 1500 r.p.m. before putting them in the 371C incubator. After 24 h, the cells were trypsinized and replicates were pooled in a 24-well plate together with 800 ml fresh viral supernatant. The mixtures were again centrifuged as mentioned above and incubated for 24 h before replacing the medium with fresh culture medium.
Transduction efficiencies were determined by measuring EGFP expression using FACS analysis (Epics Altra from Beckman Coulter, Fullerton, CA, USA). Subsequently, the cells were sorted to obtain cell populations with more than 90% EGFP-positive cells.
Western blotting analyses
Total protein extracts were prepared in RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% (v/v) Igepal, 1% (w/v) sodium deoxycholate, 5 mM iodoacetamide, 0.1% (w/v) SDS), containing complete protease inhibitor cocktail (Roche). To examine the subcellular distribution of b-catenin, cytosolic, membranous and nuclear extracts of MCF10A cells transfected with the SIP1 expression vector (or the corresponding backbone vector) for 48 h were prepared using the ProteoExtract Subcellular Proteome Extraction Kit (Calbiochem, LaJolla, CA, USA). Protein concentration was determined with the DC protein assay (BioRad, Richmond, CA, USA). In all, 10 mg or 500 ng of total protein were separated on 15% SDS-PAGE gels for analysis of vimentin in MCF10A and BT549 cells, respectively. Total protein extract of MCF10A cells (500 ng) was separated on 10% SDS-PAGE gels for E-cadherin analysis. In total, 4 mg of cytosolic or nuclear extracts and 1 mg of membranous extracts of MCF10A cells were separated on 10% SDS-PAGE to analyse the expression of b-catenin. Proteins were transferred to PVDF membranes (NEN, Boston, MA, USA), which were then blocked with 5% milk (w/v) þ 0.1% Tween 20 (w/v) in PBS for 2 h. They were then exposed to primary antibodies overnight at 41C: a monoclonal antibody (mAb) to vimentin (clone V9, Dako), an mAb to E-cadherin (BD Transduction Laboratories, San Jose, CA) or an mAb to b-catenin (either from BD Transduction Laboratories or clone 8E4 from AG Scientific, CA, USA, which is a specific antibody for the unphosphorylated form of b-catenin). The filters were then incubated with a horseradish peroxidase-conjugated swine anti-mouse antibody (Dako). Signals were detected with an enhanced chemiluminescence (ECL þ ) kit (Amersham Pharmacia Biotech, Buckinghamshire, UK). Subsequent detection of actin (using a rabbit antibody to actin, clone A2066, Sigma-Aldrich, St Louis, MO, USA), or c-myc (using an mAb to c-myc, clone 9E10, Sigma) was performed on the same filters as a control. Western blotting analyses were performed on three independent experiments and a representative experiment is shown in the figures.
RT-PCR analysis
Total RNA was extracted with an RNA isolation kit (Roche). RT-PCR was performed using 10 ng of total RNA and the GeneAmp Thermostable RNA PCR Kit (Perkin Elmer, Foster City, CA, USA). Forward and reverse primers (Eurogentec, Seraing, Belgium) were as follows: vimentin primers (forward 5 0 -GACAATGCGTCTCTGGCACGTCTT-3 0 , reverse 5 0 -TCCTCCGCCTCCTGCAGGTTCTT-3 0 ), SIP1 primers (forward 5 0 -AGTCCATGCGAACTGCCATCTGAT-3 0 , reverse 5 0 -CTGGACCATCTACAGAGGCTTGTA-3 0 ), E-cadherin primers: (forward 5 0 -CCCATCAGCTGCCCAGAAAATGA A-3 0 , reverse 5 0 -CTGTCACCTTCAGCCATCCTGTTT-3 0 ), 28S rRNA primers (forward 5 0 -GTTCACCCACTAATAGGG AACGTGA-3 0 , reverse 5 0 -GGATTCTGACTTAGAGGCGT TCAGT-3 0 ). Reverse transcription was performed at 701C for 15 min. Products were separated on acrylamide gels, stained with SYBR Gold (Molecular Probes, Eugene, OR, USA) and quantified by fluorimetric scanning (LAS-1000, Fuji, Stamford, CT, USA). Quantification was performed by normalization of the values obtained for 28S rRNA amplification. For SIP1 cDNA transfection or RNAi experiments, results were expressed as fold induction calculated by dividing the normalized value of a given condition (SIP1 cDNA transfection, SIP1 siRNA transfection or SIP1 shRNA transduction) by the normalized value of the corresponding control. Each experiment was performed at least three times. Data are expressed as means7s.e. A one-sample t-test was performed and a P-value o0.05 was considered significant.
Boyden chamber invasion assay
The migratory properties of MCF10A cells transfected with SIP1 cDNA for 48 h or transduced with the SIP1shRNA lentiviral vector were assessed using the Boyden chamber assay. Cells (100 000) were suspended in 300 ml of serum-free medium supplemented with 0.1% BSA and placed in the upper compartment of a 24-well transwell (Costar, NY, USA). The lower compartment was filled with 600 ml of medium containing 10% FCS and 1% BSA. After 6 h of incubation at 371C, the filters were fixed in methanol for 10 min and stained with Giemsa for 30 min. Cells on the upper surface of the filters were wiped away with a cotton swab. Migration was quantified by counting the number of cells on the lower surface of the filters. Experiments were performed at least three times in triplicate. Data are expressed as means7s.e. A one-sample t-test was performed and a P-value o0.05 was considered significant.
